These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 2455038

  • 1. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [Abstract] [Full Text] [Related]

  • 2. Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1983 Jun; 225(3):546-52. PubMed ID: 6864519
    [Abstract] [Full Text] [Related]

  • 3. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
    Simpson LL, Coffield JA, Bakry N.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147
    [Abstract] [Full Text] [Related]

  • 4. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N, Kamata Y, Simpson LL.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [Abstract] [Full Text] [Related]

  • 5. The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin.
    Simpson LL.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):182-7. PubMed ID: 6707933
    [Abstract] [Full Text] [Related]

  • 6. Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin.
    Simpson LL.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):600-4. PubMed ID: 6707911
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
    Simpson LL, Coffield JA, Bakry N.
    J Pharmacol Exp Ther; 1994 Apr; 269(1):256-62. PubMed ID: 8169833
    [Abstract] [Full Text] [Related]

  • 8. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL, Dasgupta BR.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [Abstract] [Full Text] [Related]

  • 9. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A.
    Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019
    [Abstract] [Full Text] [Related]

  • 10. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism.
    Simpson LL.
    Infect Immun; 1986 Jun 01; 52(3):858-62. PubMed ID: 3011675
    [Abstract] [Full Text] [Related]

  • 11. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
    Poulain B.
    Pathol Biol (Paris); 1994 Feb 01; 42(2):173-82. PubMed ID: 7916455
    [Abstract] [Full Text] [Related]

  • 12. [Structure and function of botulinum toxin].
    Fujii N.
    Hokkaido Igaku Zasshi; 1995 Jan 01; 70(1):19-28. PubMed ID: 7744367
    [Abstract] [Full Text] [Related]

  • 13. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR, Marvaud JC, Raffestin S.
    Ann Pharm Fr; 2001 May 01; 59(3):176-90. PubMed ID: 11427819
    [Abstract] [Full Text] [Related]

  • 14. [The structure and mechanism of action of clostridial neurotoxins].
    Parasion S, Bartoszcze M, Gryko R.
    Przegl Epidemiol; 2007 May 01; 61(3):519-27. PubMed ID: 18069389
    [Abstract] [Full Text] [Related]

  • 15. The interaction between aminoquinolines and presynaptically acting neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1982 Jul 01; 222(1):43-8. PubMed ID: 6283072
    [Abstract] [Full Text] [Related]

  • 16. The study of clostridial and related toxins. The search for unique mechanisms and common denominators.
    Simpson LL.
    J Physiol (Paris); 1990 Jul 01; 84(2):143-51. PubMed ID: 2290129
    [Abstract] [Full Text] [Related]

  • 17. In vitro physiological studies on clostridial neurotoxins. Biological models and procedures for extracellular and intracellular application of toxins.
    Poulain B, Bader MF, Molgó J.
    Methods Mol Biol; 2000 Jul 01; 145():259-86. PubMed ID: 10820727
    [No Abstract] [Full Text] [Related]

  • 18. Engineered toxins: new therapeutics.
    Foster KA.
    Toxicon; 2009 Oct 01; 54(5):587-92. PubMed ID: 19264086
    [Abstract] [Full Text] [Related]

  • 19. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.
    Sellin LC, Thesleff S, Dasgupta BR.
    Acta Physiol Scand; 1983 Oct 01; 119(2):127-33. PubMed ID: 6140815
    [Abstract] [Full Text] [Related]

  • 20. Identification of the site at which phospholipase A2 neurotoxins localize to produce their neuromuscular blocking effects.
    Simpson LL, Lautenslager GT, Kaiser II, Middlebrook JL.
    Toxicon; 1993 Jan 01; 31(1):13-26. PubMed ID: 8446959
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.